Successful treatment of disseminated superficial actinic porokeratosis with topical 2% cholesterol/ 2% lovastatin cream: a case series with 7 patients-Reference-Cited by-同舟云学术

Successful treatment of disseminated superficial actinic porokeratosis with topical 2% cholesterol/ 2% lovastatin cream: a case series with 7 patients

Published:2021-09-08 Issue:1 Volume:36 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Tomsitz D.¹^ORCID,Biedermann T.¹

Affiliation:

1. Department of Dermatology and Allergy School of Medicine Technical University of Munich Munich Germany

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17619

Reference10 articles.

1. Poroqueratosis. Revisión de su etiopatogenia, manifestaciones clínicas, diagnóstico y tratamiento

2. Treatment of Porokeratosis: A Systematic Review

3. Loss-of-function Mutation in PMVK Causes Autosomal Dominant Disseminated Superficial Porokeratosis

4. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis

5. Mutations in mevalonate pathway genes in patients with familial or sporadic porokeratosis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Porokeratoses: an update on pathogenesis and treatment;International Journal of Dermatology;2024-08-11

2. Konventionelle und neue Behandlungsstrategien bei Porokeratosen: Eine narrative Übersicht;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-08

3. Conventional and Novel Treatment Strategies for Porokeratoses: A Narrative Review;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-07-03

4. Autoinflammatory Keratinization Diseases—The Concept, Pathophysiology, and Clinical Implications;Clinical Reviews in Allergy & Immunology;2023-12-16

5. Porokeratoses—A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants;Metabolites;2023-11-26